Literature DB >> 8286361

Solution structure of RP 71955, a new 21 amino acid tricyclic peptide active against HIV-1 virus.

D Fréchet1, J D Guitton, F Herman, D Faucher, G Helynck, B Monegier du Sorbier, J P Ridoux, E James-Surcouf, M Vuilhorgne.   

Abstract

The structure of RP 71955, a new tricyclic 21 amino acid peptide active against human immunodeficiency virus 1, was determined. Its amino acid composition was inferred from the results of fast atom bombardment mass spectrometry, nuclear magnetic resonance, Raman spectroscopy, and amino acid analysis. Its sequence could not be determined classically, using Edman degradation, given the lack of a free terminal NH2. It was deduced from the interpretation of interresidue nuclear Overhauser effects and confirmed by the sequencing of peptides obtained by limited chemical hydrolysis. It was found to be CLGIGSCNDFAGCGYAVVCFW. An internal amide bond between the NH2 of C1 and the gamma-COOH of D9 was observed, as well as two disulfide bridges, one between C1 and C13 and one between C7 and C19. The three-dimensional structure of RP 71955 was determined from nuclear magnetic resonance derived constraints using distance geometry, restrained molecular dynamics, nuclear Overhauser effect back calculation, and an iterative refinement using a full relaxation matrix approach. Analogies between the structure of RP 71955 and some functional domains of gp41, the transmembrane protein of human immunodeficiency virus 1, suggest hypotheses concerning the mode of action of RP 71955.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8286361     DOI: 10.1021/bi00167a006

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  18 in total

1.  Inhibition of human immunodeficiency virus type 1 entry by a binding domain of Porphyromonas gingivalis gingipain.

Authors:  Hua Xie; Natalya I Belogortseva; Jie Wu; Wei-Hong Lai; Chin-ho Chen
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Structure-activity analysis of microcinJ25: distinct parts of the threaded lasso molecule are responsible for interaction with bacterial RNA polymerase.

Authors:  Ekaterina Semenova; Yulia Yuzenkova; Jean Peduzzi; Sylvie Rebuffat; Konstantin Severinov
Journal:  J Bacteriol       Date:  2005-06       Impact factor: 3.490

3.  Hitting the caspofungin salvage pathway of human-pathogenic fungi with the novel lasso peptide humidimycin (MDN-0010).

Authors:  Vito Valiante; Maria Cândida Monteiro; Jesús Martín; Robert Altwasser; Noureddine El Aouad; Ignacio González; Olaf Kniemeyer; Emilia Mellado; Sara Palomo; Nuria de Pedro; Ignacio Pérez-Victoria; José R Tormo; Francisca Vicente; Fernando Reyes; Olga Genilloud; Axel A Brakhage
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

4.  Precursor-centric genome-mining approach for lasso peptide discovery.

Authors:  Mikhail O Maksimov; István Pelczer; A James Link
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

5.  Structural mass spectrometry: rapid methods for separation and analysis of peptide natural products.

Authors:  Cody R Goodwin; Larissa S Fenn; Dagmara K Derewacz; Brian O Bachmann; John A McLean
Journal:  J Nat Prod       Date:  2012-01-04       Impact factor: 4.050

Review 6.  How to harness biosynthetic gene clusters of lasso peptides.

Authors:  Shinya Kodani; Kohta Unno
Journal:  J Ind Microbiol Biotechnol       Date:  2020-07-23       Impact factor: 3.346

7.  Siamycin attenuates fsr quorum sensing mediated by a gelatinase biosynthesis-activating pheromone in Enterococcus faecalis.

Authors:  Jiro Nakayama; Emi Tanaka; Reiko Kariyama; Koji Nagata; Kenzo Nishiguchi; Ritsuko Mitsuhata; Yumi Uemura; Masaru Tanokura; Hiromi Kumon; Kenji Sonomoto
Journal:  J Bacteriol       Date:  2006-10-27       Impact factor: 3.490

8.  Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor.

Authors:  P F Lin; H Samanta; C M Bechtold; C A Deminie; A K Patick; M Alam; K Riccardi; R E Rose; R J White; R J Colonno
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

Review 9.  Ribosomal peptide natural products: bridging the ribosomal and nonribosomal worlds.

Authors:  John A McIntosh; Mohamed S Donia; Eric W Schmidt
Journal:  Nat Prod Rep       Date:  2009-04       Impact factor: 13.423

10.  High-resolution solution structure of siamycin II: novel amphipathic character of a 21-residue peptide that inhibits HIV fusion.

Authors:  K L Constantine; M S Friedrichs; D Detlefsen; M Nishio; M Tsunakawa; T Furumai; H Ohkuma; T Oki; S Hill; R E Bruccoleri
Journal:  J Biomol NMR       Date:  1995-04       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.